结核病预后和临床协同活动与肠道微生物群
Karthikeyan Sundaram1,2, Leela Kagithakara Vajravelu2
1Department of Microbiology, Mohamed Sathak College of Arts and Science, Sholinganallur, Chennai, Tamilnadu 600119 India.
Indian journal of microbiology
|February 19, 2026
概括
结核病感染显著改变了肠道微生物群,导致了失活性. 了解这种肠-大脑轴连接可能为结核病治疗和免疫调节提供新的策略.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 结核病 (TB) 仍然是一个主要的全球健康威胁,由*Mycobacterium tuberculosis*引起.
- 肠道微生物群在宿主健康中起着至关重要的作用,并且越来越多地与结核病等传染病有关.
- 抗菌药物可以改变肠道微生物群的组成.
研究的目的:
- 审查结核病与肠道微生物群之间的关联.
- 在结核病的背景下探索肠-大脑,肠-肝脏和肠-肺轴.
- 使用肠道共生细菌识别潜在的免疫调节策略.
主要方法:
- 关于结核病和肠道微生物群的研究文献综述.
- 对结核病患者和动物模型中的微生物组成变化的分析.
- 检查短链脂肪酸 (SCFA) 生产细菌的作用.
主要成果:
- 结核病感染与肠道微生物失调症密切相关,肠道细菌的不平衡.
- 观察到特定的微生物变化,包括SCFA生产者的变化,如*Bifidobacterium*和*Ruminococcus*.
- 肠道微生物群通过肠-大脑,肠-肝脏和肠-肺轴与器官进行通信.
结论:
- 肠道微生物失调是结核病的一个关键特征.
- 准肠道微生物群可能为结核病提供新的治疗方法.
- 对肠道共生细菌的进一步研究可能会导致针对结核病的免疫调节策略.
相关概念视频
Pulmonary Tuberculosis V
656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K


